Identifying biased 5-HT1A ligands that target autoreceptor vs. heteroreceptor signaling may provide useful tools to separately target these receptors that have opposite effects on depression and SSRI response (Figure 2) (Assie et al., 2010; Becker et al., 2016). The gene discussed is HTR1A; the disease is depressive symptom measurement.